Lunai Bioworks (LNAI) Cash from Financing Activities (2011 - 2026)

Lunai Bioworks' Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 3.33% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $6.2 million (down 42.13% YoY), while the FY2025 annual figure was $8.4 million, down 20.3% from the prior year.
• Cash from Financing Activities was $3.7 million for Q1 2026 at Lunai Bioworks, up from $950000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $3.7 million in Q1 2026 to a low of -$300000.0 in Q4 2022.
• Historically, Cash from Financing Activities has averaged $1.8 million across 5 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities slumped 110.17% in 2022, then jumped 1048.96% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$300000.0 in 2022, then surged by 1048.96% to $2.8 million in 2023, then slipped by 8.99% to $2.6 million in 2024, then slumped by 63.33% to $950000.0 in 2025, then surged by 289.84% to $3.7 million in 2026.
• The last three Cash from Financing Activities figures came in at $3.7 million (Q1 2026), $950000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.